Atossa Therapeutics, Inc. (ATOS) stock gains during pre-market trading. Here’s to know why?
Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock declined by 27.51% at the last close while the ATOS stock price rises further by 9.09% in the pre-market trading session. Atossa Therapeutics is a clinical-stage biopharmaceutical business focused on discovering and developing new medications in unmet medical needs, with a current emphasis on breast cancer and COVID-19. Significant […]
Atossa Therapeutics Inc. (ATOS) stock soars during after-hour session. Here’s to know why?
Atossa Therapeutics Inc. (NASDAQ: ATOS) stock gained by 30.09% at last close while the ATOS stock price rises by 4.83% in the after-hours trading session. Atossa Therapeutics is a clinical-stage biopharmaceutical business specializing on oncology and infectious illnesses, with a current emphasis on breast cancer and COVID-19. Upcoming Important Event ATOS will offer a webinar […]
Why Atossa Therapeutics (ATOS) Is Surging 38% Pre-Market?
Before the ring of the bell today, Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company, has been seeing a 30.24% jump in its stock price. At the close of the previous session, the stock was up 16.43% to close at $2.48. Over the past 5 sessions, the stock is down -8.49% while the decline […]
